期刊文献+

促红细胞生成素在人乳腺癌细胞株中的表达及作用 被引量:1

Expression and function of erythropoietin in human breast cancer cell lines
下载PDF
导出
摘要 目的:通过检测重组人促红细胞生成素(recombinant human erythropoietin,rh-EPO)对乳腺癌细胞株增殖、凋亡及转移等生物学行为的影响,探讨EPO/EPO-R在乳腺癌发生发展中的作用。方法:运用RT-PCR、免疫细胞化学Envision法及蛋白质印迹法检测乳腺癌细胞株MCF-7和MDA-MB-231中EPO、EPO-R mRNA含量及蛋白表达;采用MTT比色试验、原位末端脱氧核糖核酸转移酶标记DNA链断端分析法(terminal deoxynucleotidyl transferase mediateddutp-Biotin nick end-labeling assay,TUNEL)、Transwell小室法观察不同浓度rh-EPO对这两种细胞增殖、凋亡和转移能力的影响。结果:MCF-7和MDA-MB-231细胞中均表达EPO及EPO-R;MTT比色试验和Transwell小室法显示,rh-EPO能增强两种细胞株的增殖活性和迁移侵袭能力,而且具有时间剂量依赖性;TUNEL法显示rh-EPO并没有抑制两株细胞凋亡的作用。rh-EPO对于MCF-7的作用效果强于MDA-MB-231细胞。结论:在不影响癌细胞凋亡的情况下,rh-EPO能够促进MCF-7和MDA-MB-231细胞的增殖活性,提高癌细胞的迁移和侵袭能力。 Objective: To detect recombinant human erythropoietin(rh-EPO) on the biological behavior of tumor cells such as proliferation,apoptosis and metastasis;and to explore the role of EPO and EPO receptor(EPO-R) in the development of breast cancer.Methods: The expression levels of EPO and EPOR in MCF-7 and MDA-MB-231 were detected by RT-PCR,immunocytochemistry and Western blotting.The proliferation abilities of MCF-7 and MDA-MB-231 cells interfered by rh-EPO in different concentration were detected by MTT assay.The Apoptosis of MCF-7 and MDA-MB-231 cells were evaluated by the terminal deoxynucleotidyl transferase mediated dutp-Biotin nick end-labeling assay(TUNEL).The migration and invasion abilities of MCF-7 and MDA-MB-231 cells were investigated by transwell technique.Results: The results of RT-PCR and Western blotting showed that EPO and EPO-R were expressed in MCF-7 and MDA-MB-231.The MTT assay and invasion assay revealed that rh-EPO could enhance the capacity of proliferation and the ability of migration and Matrigel-invasion in vitro both in MCF-7 and MDA-MB-231 cell lines in a time and dose-dependent manner.In TUNEL,the results showed that rh-EPO failed to prevent apoptosis.Conclusion: rh-EPO could enhance the capacity of proliferation and the ability of migration and Matrigel-invasion in vitro both in MCF-7 and MDA-MB-231 cell lines,and the effect on MCF-7 cells was better than that on MDA-MB-231 cells,but could not induce cell apoptosis.
出处 《江苏大学学报(医学版)》 CAS 2013年第2期124-129,共6页 Journal of Jiangsu University:Medicine Edition
基金 福建省自然科学基金资助项目(2009J01155)
关键词 MCF-7细胞 MDA-MB-231细胞 促红细胞生成素 增殖 凋亡 侵袭 乳腺癌 MCF-7 cell MDA-MB-231 cell erythropoietin proliferation apoptosis invasion breast cancer
  • 相关文献

参考文献16

  • 1Bennett CL, Silver SM, Djulbegovic B, et al. Venous thromboembolism and mortality associated with recombi- nant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia [ J ]. JAMA, 2008,299 ( 8 ) : 914 - 924.
  • 2Wincewicz A, Sulkowska M, Koda M, et al, STAT3, HIF-1α, EPO and EPOR-signaling proteins in human primary ductal breast cancers [ J ]. Folia Histochem Cyto- biol, 2007,45 (2) : 81 - 86.
  • 3Jeong JY, Feldman L, Solar P,et al. Characterization of erythropoietin receptor and erythropoietin expression and function in human ovarian cancer cells [ J ]. Int J Canc- er, 2008, 122(2) : 274 -280.
  • 4Arcasoy MO, Jiang X, Haroon ZA. Expression of eryth- ropoietin receptor splice variants in human cancer [ J l- Biochem Biophys Res Commun, 2003,307 (4) : 999 - 1007.
  • 5Leo C, Horn LC, Rauscher C, et al. Expression of erythropoietin and erythropoietin receptor in cervical cancer and relationship to survival, hypoxia, and apop- tosis[J]. Clin Cancer Res, 2006, 12(23): 6894 - 6900.
  • 6Li HG, Li JS, Chen WL, et al. Prognostic significance of erythropoietin and erythropoietin receptor in tongue squamous cell carcinoma [ J ]. Br J Oral Maxillofac Surg, 2009,47 ( 6 ) :470 - 475.
  • 7Kaster O, Simon P, Mittelbronn M. et al. Erythropoie- tin receptor is expressed in meningiomas and lower levels are associated with tumour recurrence [ J ]. Neuropathol Appl Neurobiol, 2009,35 (6) : 555 - 565.
  • 8Giatromanloaki A, Fiska A, Pitsiava D, et al. Erythro- poietin receptor in endometrial carcinoma as related to HIF1 of and VEGF expression [ J ]. In Vivo, 2009,23 (5) :699 -703.
  • 9Yasuda Y, Hara S, Hirohata T, et al. Erythropoietin-re- sponsive sites in normal and malignant human lung tis- sues[J]. Anat Sci Int,2010,85(4) :204 -213.
  • 10Peres EA, Valable S, Guillamo JS, et al. Targeting the erythropoietin receptor on glioma cells reduces tumour growth[J]. Exp Cell Res, 2011, 317(16):2321 - 2332.

二级参考文献7

  • 1Cvetkovic RS,Goa KL.Darbepoetin alfa:in patients with chemotherapy-related anaemia[J].Drugs,2003,63(11):1 067-1 077.
  • 2Henke M,Laszig R,Rube C,et al.Erythropoietin to treat head and neck cancer patients with anaemia under going radiotherapy:randomised,double-blind,placebo-controlled trial[J].Lancet,2003,362 (9 392):1 255-1 260.
  • 3Gordon MS.Managing anemia in the cancer patient:old problems,future solutions[J].Oncologist,2002,7(4):331-341.
  • 4Terry Lappin.The Cellular Biology of Erythropoietin Receptors[J].Oncologist,2003,8(Suppl 1):15-18.
  • 5Itri LM.Managing cancer related anaemia with epoetin alfa[J].Nephrol Dial Transvlant,2002,17 (Suppl 1):73-77.
  • 6Quirt I,Robeson C,Lau CY,et al.Canadian Eprex Oncology Study Group:Epoetin alfa therapy increases hemoglobin levels and improve quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy[J].J Clin Oncol,2001,19 (21):4 126-4 134.
  • 7Glaspy J,Degos L,Dicato M,et al.Comparable efficacy of epoetin alfa for anemic cancer patients receiving platinum-and non platinum-based chemotherapy:aretrospective subanalysis of two large,community based trials[J].Oncologist,2002,7(2):126-135.

同被引文献12

  • 1Sasaki R, Masuda S, Nagao M. Erythropoietin : multiple physio logical functions and regulation of biosynthesis[J]. Biosci Bio technol Biochem, 2000,64(9) : 1775-1793.
  • 2Mirmohammadsadegh A, Marini A,Gustrau A, el al. Role of eryth- ropoietin receptor expression in malignant melanoma[J]. J In- vest Dermatol,2010,130(1) =201-210.
  • 3Lopez T V, Lappin T R, Maxwell P, et al. Autocrine/paracrine erythropoietin signalling promotes JAK/STAT-dependent pro- liferation o{ human cervical cancer cells[J]. Int J Cancer,2011, 129(11) :2566 2576.
  • 4Jacobson L O,Goldwasser E,Fried W, et al. Role of the kidney in erythropoiesis[J]. Nature, 1957,179(4560) : 633-634.
  • 5Um M, Lodish H F. Antiapoptotic effects of erythropoietin in differentiated neuroblastoma SH-SY5Y cells require activation of both the STAT5 and AKT signaling pathways[J]. J Biol Chem, 2006,281 (9) : 5648-5656.
  • 6Pajonk F,Weil A,Sommer A,et al. The erythropoietin-receptor pathway modulates survival of cancer cells[J]. Oncogene,2004, 23(55) :8987-8991.
  • 7Xie Z,Chen F,Wu X,et al. Effects of supplemental erythropoie- tin on its receptor expression and signal transduction pathways in rat model o[ retina] detachment[J]. Curt Eye Res, 2012,37 (2) 138-144.
  • 8Nagata Y,Takahashi N,Davis R J,et al. Activation of p38 MAP ki nase and JNK but not ERK is required for erythropoietin-in duced erythroid differentiation[J]. Blood, 1998, 92 (6) : 1859-1869.
  • 9Liang K, Esteva F J, Albarracin C, et al. Recombinant human erythropoietin antagonizes trastuzurnab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inacti- vation[J]. Cancer Ce11,2010,18(5) :423-435.
  • 10Guihard S, Clay D, Cocautt L, et al. The MAPK ERK1 is a negative regulator of the adult steady-state splenic erythropoi- esis[J]. Blood,2010,115(18) :3686 3694.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部